AnalystsPaul MatteisPaul Matteis's Stock Forecasts
AnalystsPaul Matteis
Analyst Ranking
Bottom 4%
#4770 out of 4944 analysts
Average Return
-10.09%
Win Rate
36%26 out of 72
Risk vs Reward
Poor
Good
Paul Matteis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | +71.19% | $52.97 | $90.68 | 2025-03-05 - 2025-07-17 | Strong Buy |
Gw Pharmaceuticals PLCGWPH | +64.79% | $98.51 | $162.33 | 2017-10-02 - 2018-10-02 | Buy |
Gh Research PLCGHRS | +61.97% | $10.65 | $17.25 | 2025-02-27 - 2025-07-17 | Strong Buy |
Neurocrine Biosciences IncNBIX | +59.15% | $72.78 | $115.83 | 2017-11-02 - 2018-11-02 | Buy |
Avadel Pharmaceuticals PLCAVDL | +53.86% | $6.35 | $9.77 | 2020-03-12 - 2021-03-12 | Strong Buy |
Paul Matteis Analyst Color
Get additional color on Paul Matteis's coverage of popular stocks
Paul Matteis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $94.00 | +3.66% | Maintains | 2 months ago |
Vigil Neuroscience IncVIGL | 2 | Hold | $8.00 | -0.99% | Downgrades | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $345.00 | +6.26% | Maintains | 4 months ago |
Neumora Therapeutics IncNMRA | 2 | Hold | $2.00 | +16.96% | Downgrades | 4 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $32.00 | +74.58% | Initiates Coverage On | 5 months ago |
Gh Research PLCGHRS | 2 | Strong Buy | $32.00 | +85.51% | Maintains | 5 months ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $11.00 | +183.51% | Initiates Coverage On | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 13 | Hold | $494.00 | +6.63% | Maintains | 7 months ago |
Uniqure NvQURE | 1 | Strong Buy | $32.00 | +110.53% | Maintains | 7 months ago |
Sage Therapeutics IncSAGE | 5 | Hold | $6.00 | -34.35% | Maintains | 7 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $37.00 | +154.65% | Upgrades | 7 months ago |
Alector IncALEC | 5 | Hold | $4.00 | +139.52% | Downgrades | 7 months ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $10.00 | +247.22% | Maintains | 8 months ago |
Neurogene IncNGNE | 2 | Strong Buy | $60.00 | +165.49% | Maintains | 8 months ago |
Alkermes PLCALKS | 5 | Strong Buy | $36.00 | +22.62% | Upgrades | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 8 | Strong Buy | $87.00 | +49.05% | Maintains | 10 months ago |
Dyne Therapeutics IncDYN | 3 | Strong Buy | $66.00 | +602.13% | Maintains | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Ionis Pharmaceuticals IncIONS | 4 | Hold | $53.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 5 | Hold | $21.00 | N/A | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 5 | Strong Buy | $144.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 6 | Strong Buy | $287.00 | N/A | Maintains | 2 years ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Pepgen IncPEPG | 2 | Strong Buy | $24.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $295.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Strong Buy | $54.00 | N/A | Maintains | 3 years ago |
Athira Pharma IncATHA | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Climb Bio IncCLYM | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 4 | Hold | $140.00 | N/A | Downgrades | 5 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 5 years ago |
Zogenix IncZGNX | 3 | Buy | $60.00 | N/A | Initiates Coverage On | 7 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $2,280.00 | N/A | Maintains | 7 years ago |
Akcea Therapeutics IncAKCA | 2 | Hold | $31.00 | N/A | Maintains | 7 years ago |
Obseva SaOBSVF | 1 | Buy | $18.00 | N/A | Maintains | 7 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $64.00 | N/A | Maintains | 7 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $340.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.